Gensco Pharma
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8550 NW 33rd St, Doral, Florida, 33122, ...Website
www.genscopharma.comRevenue
$9.8 MillionIndustry
About Gensco Pharma
Gensco Pharma is a specialty pharmaceutical company that focuses on innovative drug delivery technologies and unique preparations to enhance health outcomes. Their product line includes transdermal systems, topical anesthetics, and pain relief solutions such as LidoDose, ColciGel, and SpeedGel Rx. Gensco Pharma targets healthcare professionals and patients seeking effective and convenient treatment options. The company is also expanding its portfolio with the upcoming launch of RizaFilm, a novel migraine treatment.Explore more
Gensco Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Gensco Pharma
Compare insights from companies similar to Gensco Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Gensco Pharma Tech Stack
A closer look at the technologies used by Gensco Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gensco Pharma
Sign Up For FreeTo access detailed company insights
Gensco Pharma is a specialty pharmaceutical company that focuses on innovative drug delivery technologies and unique preparations to enhance health outcomes. Their product line includes transdermal systems, topical anesthetics, and pain relief solutions such as LidoDose, ColciGel, and SpeedGel Rx. Gensco Pharma targets healthcare professionals and... Read More
